Atabak Mokari
CIK 1678419 · Chief Financial Officer · last filed 2026-06-03
Atabak Mokari is a Chief Financial Officer who has filed 27 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for CORT, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.43M
3
27
-$2.80M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Chief Financial Officer | 16,130 | $82.91 | $1.34M | -$2.80M | 20 | 2026-06-03 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Chief Financial Officer | — | $0.07 | — | $0 | 3 | 2020-04-09 |
| IRIX | CFO and VP Corp Development | 81,967 | $1.12 | $91.8K | $0 | 4 | 2018-12-13 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | CORT | Mixed | +873 | -$2.01M | EDGAR |
| 2026-03-04 | CORT | Mixed | +698 | $10.8K | EDGAR |
| 2026-03-03 | CORT | Grant (A) | — | $0 | EDGAR |
| 2025-12-03 | CORT | Mixed | +238 | $4.8K | EDGAR |
| 2025-09-04 | CORT | Mixed | +256 | $4.0K | EDGAR |
| 2025-06-04 | CORT | Mixed | +1,031 | $18.4K | EDGAR |
| 2025-03-04 | CORT | Mixed | +236 | -$108 | EDGAR |
| 2024-12-04 | CORT | Mixed | +280 | $3.2K | EDGAR |
| 2024-09-05 | CORT | Mixed | +657 | $8.7K | EDGAR |
| 2024-06-05 | CORT | Mixed | +2,325 | $28.1K | EDGAR |